Celldex Therapeutics, Inc. Comprehensive Income
Celldex Therapeutics, Inc. (CLDX) reported Comprehensive Income of -$74.73 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-06
- Celldex Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$74.73M.
- Celldex Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$79.79M.
- Celldex Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$81.46M.
- Celldex Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$66.62M.
- Celldex Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$258.44M.
- Celldex Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$157.86M.
- Celldex Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$139.38M.
- Celldex Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$112.96M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$74.73M 10-Q · filed 2026-08-06 | -$154.52M 10-Q · filed 2026-08-06 | -$235.97M derived: sum of 3 quarters · filed 2026-08-06 | -$302.59M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$79.79M 10-Q · filed 2026-05-07 | -$161.25M derived: sum of 2 quarters · filed 2026-05-07 | -$227.86M derived: sum of 3 quarters · filed 2026-05-07 | -$284.69M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$81.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$148.07M derived: sum of 2 quarters · filed 2026-02-25 | -$204.90M derived: sum of 3 quarters · filed 2026-08-06 | -$258.44M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$66.62M 10-Q · filed 2025-11-10 | -$123.45M derived: sum of 2 quarters · filed 2026-08-06 | -$176.99M 10-Q · filed 2025-11-10 | -$226.06M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$56.83M 10-Q · filed 2026-08-06 | -$110.37M 10-Q · filed 2026-08-06 | -$159.44M derived: sum of 3 quarters · filed 2026-08-06 | -$198.05M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$53.54M 10-Q · filed 2026-05-07 | -$102.61M derived: sum of 2 quarters · filed 2026-05-07 | -$141.22M derived: sum of 3 quarters · filed 2026-05-07 | -$177.53M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$49.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$87.68M derived: sum of 2 quarters · filed 2026-02-25 | -$123.98M derived: sum of 3 quarters · filed 2026-02-25 | -$157.86M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$38.61M 10-Q · filed 2025-11-10 | -$74.92M derived: sum of 2 quarters · filed 2025-11-10 | -$108.79M 10-Q · filed 2025-11-10 | -$150.92M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$36.31M 10-Q · filed 2025-08-07 | -$70.18M 10-Q · filed 2025-08-07 | -$112.31M derived: sum of 3 quarters · filed 2026-02-25 | -$150.51M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$33.87M 10-Q · filed 2025-05-08 | -$76.00M derived: sum of 2 quarters · filed 2026-02-25 | -$114.20M derived: sum of 3 quarters · filed 2026-02-25 | -$144.75M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$42.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$80.33M derived: sum of 2 quarters · filed 2026-02-25 | -$110.88M derived: sum of 3 quarters · filed 2026-02-25 | -$139.38M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$38.20M 10-Q · filed 2024-11-06 | -$68.75M derived: sum of 2 quarters · filed 2024-11-06 | -$97.25M 10-Q · filed 2024-11-06 | -$122.36M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$30.55M 10-Q · filed 2024-08-08 | -$59.05M 10-Q · filed 2024-08-08 | -$84.17M derived: sum of 3 quarters · filed 2025-02-27 | -$110.64M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$28.50M 10-Q · filed 2024-05-06 | -$53.61M derived: sum of 2 quarters · filed 2025-02-27 | -$80.09M derived: sum of 3 quarters · filed 2025-02-27 | -$116.63M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$25.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$51.59M derived: sum of 2 quarters · filed 2025-02-27 | -$88.13M derived: sum of 3 quarters · filed 2025-02-27 | -$112.96M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$26.48M 10-Q · filed 2023-11-02 | -$63.01M derived: sum of 2 quarters · filed 2023-11-02 | -$87.84M 10-Q · filed 2023-11-02 | -$108.65M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | -$36.53M 10-Q · filed 2023-08-08 | -$61.37M 10-Q · filed 2023-08-08 | -$82.17M derived: sum of 3 quarters · filed 2024-02-26 | -$102.66M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | -$24.83M 10-Q · filed 2023-05-04 | -$45.63M derived: sum of 2 quarters · filed 2024-02-26 | -$66.13M derived: sum of 3 quarters · filed 2024-02-26 | -$79.50M derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | -$20.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | -$41.30M derived: sum of 2 quarters · filed 2024-02-26 | -$54.67M derived: sum of 3 quarters · filed 2024-02-26 | -$71.21M 10-K · filed 2024-02-26 |
| 2021-09-30 | -$20.50M 10-Q · filed 2022-11-09 | -$33.86M derived: sum of 2 quarters · filed 2022-11-09 | -$50.40M 10-Q · filed 2022-11-09 | -$72.32M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$13.37M 10-Q · filed 2022-08-08 | -$29.91M 10-Q · filed 2022-08-08 | -$51.83M derived: sum of 3 quarters · filed 2023-02-28 | -$66.04M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$16.54M 10-Q · filed 2022-05-05 | -$38.46M derived: sum of 2 quarters · filed 2023-02-28 | -$52.67M derived: sum of 3 quarters · filed 2023-02-28 | -$63.70M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$21.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$36.13M derived: sum of 2 quarters · filed 2023-02-28 | -$47.16M derived: sum of 3 quarters · filed 2023-02-28 | -$59.81M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$14.21M 10-Q · filed 2021-11-09 | -$25.24M derived: sum of 2 quarters · filed 2021-11-09 | -$37.89M 10-Q · filed 2021-11-09 | -$48.35M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$11.03M 10-Q · filed 2021-08-05 | -$23.68M 10-Q · filed 2021-08-05 | -$34.14M derived: sum of 3 quarters · filed 2022-02-28 | -$45.56M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$12.65M 10-Q · filed 2021-05-06 | -$23.11M derived: sum of 2 quarters · filed 2022-02-28 | -$34.53M derived: sum of 3 quarters · filed 2022-02-28 | -$46.27M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$10.46M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$21.88M derived: sum of 2 quarters · filed 2022-02-28 | -$33.62M derived: sum of 3 quarters · filed 2022-02-28 | -$50.84M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$11.42M 10-Q · filed 2020-11-05 | -$23.16M derived: sum of 2 quarters · filed 2020-11-05 | -$40.38M 10-Q · filed 2020-11-05 | -$49.78M derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-06-30 | -$11.74M 10-Q · filed 2020-08-06 | -$28.96M 10-Q · filed 2020-08-06 | -$38.37M derived: sum of 3 quarters · filed 2021-03-29 | -$45.62M derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-03-31 | -$17.22M 10-Q · filed 2020-05-06 | -$26.62M derived: sum of 2 quarters · filed 2021-03-29 | -$33.87M derived: sum of 3 quarters · filed 2021-03-29 | -$50.25M derived: sum of 4 quarters · filed 2021-03-29 |
| 2018-12-31 | -$9.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | -$16.65M derived: sum of 2 quarters · filed 2021-03-29 | -$33.03M derived: sum of 3 quarters · filed 2021-03-29 | -$151.16M 10-K · filed 2021-03-29 |
| 2018-09-30 | -$7.25M 10-Q · filed 2019-11-12 | -$23.63M derived: sum of 2 quarters · filed 2019-11-12 | -$141.76M 10-Q · filed 2019-11-12 | -$145.63M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-06-30 | -$16.38M 10-Q · filed 2019-08-07 | -$134.51M 10-Q · filed 2019-08-07 | -$138.38M derived: sum of 3 quarters · filed 2020-03-26 | -$164.73M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-03-31 | -$118.14M 10-Q · filed 2019-05-07 | -$122.00M derived: sum of 2 quarters · filed 2020-03-26 | -$148.35M derived: sum of 3 quarters · filed 2020-03-26 | -$176.91M derived: sum of 4 quarters · filed 2020-03-26 |
| 2017-12-31 | -$3.87M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$30.22M derived: sum of 2 quarters · filed 2020-03-26 | -$58.77M derived: sum of 3 quarters · filed 2020-03-26 | -$93.01M 10-K · filed 2020-03-26 |
| 2017-09-30 | -$26.35M 10-Q · filed 2018-11-07 | -$54.90M derived: sum of 2 quarters · filed 2018-11-07 | -$89.14M 10-Q · filed 2018-11-07 | -$121.52M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | -$28.55M 10-Q · filed 2018-08-08 | -$62.79M 10-Q · filed 2018-08-08 | -$95.17M derived: sum of 3 quarters · filed 2019-03-07 | -$124.88M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | -$34.24M 10-Q · filed 2018-05-10 | -$66.62M derived: sum of 2 quarters · filed 2019-03-07 | -$96.33M derived: sum of 3 quarters · filed 2019-03-07 | -$128.24M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | -$32.38M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$62.09M derived: sum of 2 quarters · filed 2019-03-07 | -$94.00M derived: sum of 3 quarters · filed 2019-03-07 | -$128.30M 10-K · filed 2019-03-07 |
| 2016-09-30 | -$29.71M 10-Q · filed 2017-11-07 | -$61.63M derived: sum of 2 quarters · filed 2017-11-07 | -$95.92M 10-Q · filed 2017-11-07 | -$128.86M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | -$31.92M 10-Q · filed 2017-08-08 | -$66.21M 10-Q · filed 2017-08-08 | -$99.15M derived: sum of 3 quarters · filed 2018-03-07 | -$131.00M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | -$34.29M 10-Q · filed 2017-05-09 | -$67.23M derived: sum of 2 quarters · filed 2018-03-07 | -$99.09M derived: sum of 3 quarters · filed 2018-03-07 | -$131.63M derived: sum of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | -$32.94M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | -$64.79M derived: sum of 2 quarters · filed 2018-03-07 | -$97.33M derived: sum of 3 quarters · filed 2018-03-07 | -$127.48M 10-K · filed 2018-03-07 |
| 2015-09-30 | -$31.86M 10-Q · filed 2016-11-07 | -$64.39M derived: sum of 2 quarters · filed 2016-11-07 | -$94.54M 10-Q · filed 2016-11-07 | -$126.40M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | -$32.54M 10-Q · filed 2016-08-08 | -$62.69M 10-Q · filed 2016-08-08 | -$94.54M derived: sum of 3 quarters · filed 2017-03-14 | -$122.75M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | -$30.15M 10-Q · filed 2016-05-05 | -$62.00M derived: sum of 2 quarters · filed 2017-03-14 | -$90.21M derived: sum of 3 quarters · filed 2017-03-14 | -$118.41M derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | -$31.86M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | -$60.06M derived: sum of 2 quarters · filed 2017-03-14 | -$88.26M derived: sum of 3 quarters · filed 2017-03-14 | -$118.16M 10-K · filed 2017-03-14 |
| 2014-09-30 | -$28.21M 10-Q · filed 2015-11-05 | -$56.40M derived: sum of 2 quarters · filed 2015-11-05 | -$86.30M 10-Q · filed 2015-11-05 | -$108.38M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | -$28.20M 10-Q · filed 2015-08-10 | -$58.10M 10-Q · filed 2015-08-10 | -$80.18M derived: sum of 3 quarters · filed 2016-02-25 | -$103.18M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | -$29.90M 10-Q · filed 2015-04-29 | -$51.98M derived: sum of 2 quarters · filed 2016-02-25 | -$74.98M derived: sum of 3 quarters · filed 2016-02-25 | -$94.14M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | -$22.08M derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-02-25 | -$45.08M derived: sum of 2 quarters · filed 2016-02-25 | -$64.24M derived: sum of 3 quarters · filed 2016-02-25 | -$81.63M 10-K/A · filed 2016-02-25 |
| 2013-09-30 | -$23.00M 10-Q · filed 2014-11-05 | -$42.16M derived: sum of 2 quarters · filed 2014-11-05 | -$59.55M 10-Q · filed 2014-11-05 | -$76.38M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | -$19.16M 10-Q · filed 2014-08-07 | -$36.55M 10-Q · filed 2014-08-07 | -$53.38M derived: sum of 3 quarters · filed 2015-02-24 | -$68.36M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | -$17.39M 10-Q · filed 2014-05-01 | -$34.23M derived: sum of 2 quarters · filed 2015-02-24 | -$49.20M derived: sum of 3 quarters · filed 2015-02-24 | -$63.01M derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | -$16.84M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$31.81M derived: sum of 2 quarters · filed 2015-02-24 | -$45.62M derived: sum of 3 quarters · filed 2015-02-24 | -$59.03M 10-K · filed 2015-02-24 |
| 2012-09-30 | -$14.97M 10-Q · filed 2013-11-08 | -$28.79M derived: sum of 2 quarters · filed 2013-11-08 | -$42.19M 10-Q · filed 2013-11-08 | -$54.93M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | -$13.81M 10-Q · filed 2013-08-06 | -$27.22M 10-Q · filed 2013-08-06 | -$39.95M derived: sum of 3 quarters · filed 2014-03-03 | -$51.84M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | -$13.41M 10-Q · filed 2013-05-03 | -$26.14M derived: sum of 2 quarters · filed 2014-03-03 | -$38.03M derived: sum of 3 quarters · filed 2014-03-03 | -$48.25M derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | -$12.73M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$24.63M derived: sum of 2 quarters · filed 2014-03-03 | -$34.85M derived: sum of 3 quarters · filed 2014-03-03 | -$44.90M 10-K · filed 2014-03-03 |
| 2011-09-30 | -$11.89M 10-Q · filed 2012-11-02 | -$22.11M derived: sum of 2 quarters · filed 2012-11-02 | -$32.16M 10-Q · filed 2012-11-02 | |
| 2011-06-30 | -$10.22M 10-Q · filed 2012-08-09 | -$20.27M 10-Q · filed 2012-08-09 | ||
| 2011-03-31 | -$10.05M 10-Q · filed 2012-05-04 | |||
| 2010-12-31 | -$2.33M 10-K · filed 2013-03-08 | |||
| 2009-12-31 | -$36.59M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |